Cloud Banner

Medical Devices

Image

Australia Endotoxin Testing Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Feb 2023
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Australia Endotoxin Testing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 9.8% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 20.57 Billion
Diagram Market Size (Forecast Year) USD 43.46 Billion
Diagram CAGR 9.8%

Australia Endotoxin Testing Market, By Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others) – Industry Trends and Forecast to 2030.

Australia Endotoxin Testing Market Analysis and Size

The rapidly increasing pharmaceutical and medical device industries are a major driver for the market's growth. The rising inclination towards outsourcing to contract manufacturing organizations for endotoxin testing and other contamination testing purposes has increased considerably in recent years. Public and regulatory concerns about product safety would also increase more use of endotoxin testing. High demand for R&D investments in the life sciences industry would also boost the market.

Data Bridge Market Research analyses a growth rate in the Australia endotoxin testing market in the forecast period 2023-2030. The expected CAGR of the endotoxin testing market tends to be around 9.8% in the mentioned forecast period. The market was valued at USD 20.57 million in 2022 and would grow to USD 43.46 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Australia Endotoxin Testing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2030

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Endotoxin Detection Kits & Reagents, Instruments, Systems, and Software, Endotoxin Testing Services and Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test and Recombinant C (RFC) Assay), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production and Packaging Manufacture), Method (Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, and Turbidimetric Endotoxin Test), Mode of Purchase (Large Group, Mid and Small Group and Individual), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Academic Research Institute and Others)

Market Players Covered

Eurofins Scientific (France), Thermo Fisher Scientific (U.S.), Pall Corporation. (U.S.), Lonza (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), STERIS (U.K.), Société Générale de Surveillance SA (France), Sartorius AG (Germany), and GenScript (U.S.)

Market Opportunities

  • Increasing Product Launches Associated with Endotoxin Testing
  • Increasing Rate of Development of Advanced Tests

Market Definition

Bacterial endotoxin testing (BET) is a crucial safety condition in the biomedical and pharmaceutical industries. Endotoxins can cause symptoms of septic shock, fever, and pyrogenic reaction if enough of them reach the patient's bloodstream. Identifying bacterial endotoxins is a major safety requirement in the biomedical and pharmaceutical industries. Endotoxin quality-control tests must obey the regulatory criteria laid down by the European and the U.S. Pharmacopeia and the U.S. FDA.   

Australia Endotoxin Testing Market Dynamics

Drivers

  • Increasing R&D Activities Associated with Endotoxin Testing

The increasing investments in research and development in the pharmaceutical and biotechnology industries lead to market growth. Pharmaceutical, biotech, and numerous drug manufacturing companies use tests such as pyrogen testing for the safe manufacturing and introduction of infection-free products into the market. For instance, major market players in the pharmaceuticals market named, AstraZeneca, Roche, and Merck have invested heavily in R&D activities in 2021. Roche invested about $13.5 billion, up by 14.3% from 2020. Thus, high investments in R&D by pharmaceutical companies boost market growth.

Opportunities

  • Increasing Rate of Development of Advanced Tests

Several new endotoxin testing techniques, such as recombinant factor C assay and monocyte activation test, have been developed and commercially distributed on a large scale due to high technological development. The turbidimetric endotoxin test, also known as the kinetic chromogenic Limulus amebocyte lysate (LAL) assay, is widely used to quantitatively determine bacterial endotoxins in pharmaceutical products and medical devices. The Limulus amebocyte lysate (LAL) test is widely used for drugs and devices in the pharmaceutical and biotechnology industries. Thus, this boosts market growth.  

  • Increasing Product Launches Associated with Endotoxin Testing

Numerous product launches and agreements are initiated by the companies, accelerating market growth. For instance, Charles River Laboratories launched new solutions named EndoScan-V software platform and Celsis automated detection platform for the sterility to meet pharmaceuticals needs. This new product launched by the company has boosted the company's microbial solutions portfolio, which will increase sales and revenue in the future. Also, WuXi AppTec launched its new medical device laboratory testing center in Suzhou, China, to form a globally integrated medical device testing platform to serve medical device customers and offer endotoxin testing services in 2020. This creates more opportunities in the market.

Restraints/Challenges

  • Stringent Regulations of Endotoxin Testing

There are many regulations associated with endotoxin testing methods that are stringent. These quality control tests are necessary to comply with certain regulations. For instance, ACell Inc., a Maryland-based medical device manufacturer, was found guilty on the charges related to MicroMatrix powder wound dressing product by the Department of Justice in 2019.

This endotoxin testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endotoxin testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Australia Endotoxin Testing Market Scope

The endotoxin testing market is segmented based on product type, test type, application, method, mode of purchase, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Endotoxin Detection Kits & Reagents
  • Instruments, Systems, and Software
  • Endotoxin Testing Services
  • Consumables & Accessories

Test Type

  • Limulus Amoebocyte Lysate (LAL) Test
  • Monocyte Activation Test (MAT)
  • Rabbit Pyrogen Test and Recombinant C (RFC) Assay

Application

  • Pharmaceutical Manufacturing
  • Medical Device Manufacturing
  • Raw Materials Production
  • Packaging Manufacture

Method

  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test

Mode of Purchase

  • Large Group
  • Mid and Small Group
  • Individual

End-Users

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Contract Research Organization (CRO)
  • Contract Manufacturing Organization (CMO)
  • Academic Research Institute and Others

Competitive Landscape and Australia Endotoxin Testing Market Share Analysis

The endotoxin testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endotoxin testing market.

Key players operating in the endotoxin testing market include:

  • Viatris Inc.(U.S.)
  • Eurofins Scientific (France)
  • Thermo Fisher Scientific (U.S.)
  • Pall Corporation. (U.S.)
  • Lonza (Switzerland)
  • Charles River Laboratories (U.S.)
  • Merck KGaA (Germany)
  • STERIS (U.K.)
  • Société Générale de Surveillance SA (France)
  • Sartorius AG (Germany)
  • GenScript (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Australia Endotoxin Testing Market is projected to grow at a CAGR of 9.8% during the forecast period by 2030.
The future market value of the Australia Endotoxin Testing Market is expected to reach USD 43.46 million by 2030.
The major players in the Australia Endotoxin Testing Market are Eurofins Scientific (France), Thermo Fisher Scientific (U.S.), Pall Corporation. (U.S.), Lonza (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), STERIS (U.K.), Société Générale de Surveillance SA (France), Sartorius AG (Germany), and GenScript (U.S.).
The Australia Endotoxin Testing Market is segmented on the basis of product type, test type, application, method, mode of purchase, and end user.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials